Kadimastem Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
IL0011284614
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.87M 9.21B |
---|---|---|---|---|---|
Net income 2022 | -22M -8.15B | Net income 2023 | -12M -4.45B | EV / Sales 2022 | - |
Net Debt 2022 | 739K 274M | Net Debt 2023 | 2.17M 804M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.76
x | P/E ratio 2023 |
-2.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.92% |
Managers | Title | Age | Since |
---|---|---|---|
Asaf Shiloni
CEO | Chief Executive Officer | 54 | 21-01-31 |
Michel Revel
FOU | Founder | 85 | 08-10-05 |
Uri Ben-Or
DFI | Director of Finance/CFO | 52 | 22-06-13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 20-12-16 | |
Tamar Galili
BRD | Director/Board Member | 51 | 22-01-02 |
Ronen Twito
CHM | Chairman | 49 | 20-12-22 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |